Case Western Reserve University

Case Western Reserve University

IGA MEDIATED DEFENSES AGAINST HIV-1 by ALISON LAING WRIGHT Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Advisor: Dr. Yung T. Huang, Ph.D. Department of Pathology CASE WESTERN RESERVE UNIVERSITY May, 2008 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________Alison Laing Wright candidate for the ______________________degreePh.D *. Dr. Steven Emancipator (signed)_______________________________________________ (chair of the committee) Dr. Yung Huang ________________________________________________ Dr. Michael Lamm ________________________________________________ Dr. Thomas Blanchard ________________________________________________ Dr. David McDonald ________________________________________________ Dr. Clive Hamlin ________________________________________________ (date) _______________________ January 16th 2008 *We also certify that written approval has been obtained for any proprietary material contained therein. Table of Contents Title Page ...................................................................................................................................................... 1 Committee Signatures ................................................................................................................................ 2 Table of Contents ....................................................................................................................................... 3 List of Tables ............................................................................................................................................... 6 List of Figures ............................................................................................................................................. 7 Acknowledgments ...................................................................................................................................... 8 Abbreviations .............................................................................................................................................. 9 Abstract ...................................................................................................................................................... 12 Chapter I Introduction ............................................................................................................................ 14 Origin and Classification of Human Immunodeficiency Virus ......................................... 14 HIV Infection Levels ................................................................................................................. 16 HIV Genome and Structure .................................................................................................... 17 HIV Life Cycle ............................................................................................................................ 18 HIV Co-Receptor Usage .......................................................................................................... 20 Mucosal Surface .......................................................................................................................... 21 HIV Entry at the Mucosal Surface ......................................................................................... 22 Early HIV Infection ................................................................................................................... 23 HIV Infection ............................................................................................................................. 26 Mucosal Immunological Responses ....................................................................................... 28 Immunoglobulin A Pathway .................................................................................................... 30 Polymeric Immunoglobulin Expression ................................................................................ 32 Immunoglobulin A Functions ................................................................................................. 32 IgA Neutralization of Viruses .................................................................................................. 34 Antibodies against HIV............................................................................................................. 35 Chapter II Intracellular Neutralization ................................................................................................. 39 Introduction ....................................................................................................................................... 39 Intracellular Neutralization ....................................................................................................... 39 Heterogeneity of HIV ............................................................................................................... 41 Epithelial Infection .................................................................................................................... 41 Intrabodies ................................................................................................................................... 42 Gag and RT ................................................................................................................................. 43 Materials and Methods ..................................................................................................................... 46 Cell Culture .................................................................................................................................. 46 Polarized Cell Preparation ........................................................................................................ 47 Virus .............................................................................................................................................. 48 Monoclonal Antibodies ............................................................................................................. 48 Transcytosis of Ab ..................................................................................................................... 50 Analysis of Ig content by ELISA ............................................................................................ 51 Traditional HIV Neutralization ............................................................................................... 52 Intracellular HIV Neutralization ............................................................................................. 53 HeLa Blue Cell Assay ................................................................................................................ 54 HIV p24 Assay ........................................................................................................................... 55 Preparation of Conditioned Media ......................................................................................... 56 3 Intracellular Colocalization of IgA and HIV Proteins ........................................................ 57 Data Analysis ............................................................................................................................... 58 Intracellular Neutralization Results ................................................................................................ 59 Monoclonal Antibodies ............................................................................................................. 59 Transcytosis of RT and Gag IgA ............................................................................................ 59 Intracellular HIV Neutralization ............................................................................................. 60 Concentration Dependence of Neutralization ..................................................................... 62 Confirmation that Neutralization is Intraepithelial .............................................................. 65 Effect on p24 Synthesis ............................................................................................................ 66 No Intracellular Neutralization Synergy ................................................................................ 67 Intracellular Colocalization of Viral Antigen and Antibody .............................................. 69 Intracellular Neutralization Discussion ......................................................................................... 71 Chapter III Excretion of HIV-1 by Immunoglobulin A .................................................................. 77 Introduction ....................................................................................................................................... 77 Excretion of HIV ....................................................................................................................... 77 Materials and Methods ..................................................................................................................... 80 Cell Culture .................................................................................................................................. 80 Virus .............................................................................................................................................. 81 Monoclonal Antibodies ............................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    144 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us